| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.031 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0077 | 0.9 |